Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.530
-0.080 (-3.07%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vistagen Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 84.25 | 119.17 | 16.64 | 68.14 | 103.11 | 1.36 | Upgrade
|
| Cash & Short-Term Investments | 97.58 | 119.17 | 16.64 | 68.14 | 103.11 | 1.36 | Upgrade
|
| Cash Growth | 159.46% | 616.23% | -75.58% | -33.92% | 7508.91% | -89.66% | Upgrade
|
| Other Receivables | - | - | - | 0.34 | 0.04 | - | Upgrade
|
| Receivables | - | - | - | 0.34 | 0.04 | - | Upgrade
|
| Prepaid Expenses | 2.37 | 1.43 | 0.8 | 0.2 | 0.12 | 0.11 | Upgrade
|
| Other Current Assets | - | 0.07 | 0.07 | 2.33 | 0.85 | 0.12 | Upgrade
|
| Total Current Assets | 99.95 | 120.67 | 17.51 | 71 | 104.12 | 1.58 | Upgrade
|
| Property, Plant & Equipment | 2.05 | 2.26 | 2.77 | 3.08 | 3.59 | 3.79 | Upgrade
|
| Long-Term Deferred Charges | - | 0.63 | 0.71 | 0.47 | 0.53 | 0.36 | Upgrade
|
| Other Long-Term Assets | 0.5 | 0.1 | 0.1 | 0.1 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 102.5 | 123.65 | 21.09 | 74.64 | 108.28 | 5.77 | Upgrade
|
| Accounts Payable | 0.72 | 1.55 | 2.47 | 2.76 | 0.84 | 1.84 | Upgrade
|
| Accrued Expenses | 3.82 | 2.24 | 0.8 | 1.33 | 1.56 | 0.56 | Upgrade
|
| Short-Term Debt | - | - | 0.11 | - | - | 0.06 | Upgrade
|
| Current Portion of Leases | 0.53 | 0.55 | 0.49 | 0.43 | 0.37 | 0.32 | Upgrade
|
| Current Unearned Revenue | 2.47 | 0.79 | 0.71 | 1.24 | 1.42 | - | Upgrade
|
| Total Current Liabilities | 7.52 | 5.12 | 4.57 | 5.77 | 4.19 | 2.77 | Upgrade
|
| Long-Term Leases | 1.27 | 1.57 | 2.12 | 2.61 | 3.35 | 3.72 | Upgrade
|
| Long-Term Unearned Revenue | 0.73 | 2.67 | 2.32 | 1.56 | 2.49 | - | Upgrade
|
| Total Liabilities | 9.52 | 9.37 | 9.01 | 9.93 | 10.03 | 6.49 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.01 | 0.01 | 0.18 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 476.8 | 474.44 | 342.89 | 336.28 | 315.6 | 200.09 | Upgrade
|
| Retained Earnings | -379.91 | -356.21 | -326.85 | -267.6 | -219.84 | -201.91 | Upgrade
|
| Treasury Stock | -3.97 | -3.97 | -3.97 | -3.97 | -3.97 | -3.97 | Upgrade
|
| Comprehensive Income & Other | 0.02 | - | - | - | - | - | Upgrade
|
| Total Common Equity | 92.97 | 114.29 | 12.08 | 64.72 | 91.97 | -5.73 | Upgrade
|
| Shareholders' Equity | 92.97 | 114.29 | 12.08 | 64.72 | 98.25 | -0.72 | Upgrade
|
| Total Liabilities & Equity | 102.5 | 123.65 | 21.09 | 74.64 | 108.28 | 5.77 | Upgrade
|
| Total Debt | 1.79 | 2.12 | 2.71 | 3.04 | 3.72 | 4.09 | Upgrade
|
| Net Cash (Debt) | 95.78 | 117.05 | 13.93 | 65.1 | 99.39 | -2.74 | Upgrade
|
| Net Cash Growth | 171.89% | 740.43% | -78.61% | -34.50% | - | - | Upgrade
|
| Net Cash Per Share | 3.16 | 6.05 | 2.00 | 9.86 | 34.62 | -1.87 | Upgrade
|
| Filing Date Shares Outstanding | 27.84 | 27.03 | 7.87 | 6.89 | 6.38 | 1.86 | Upgrade
|
| Total Common Shares Outstanding | 27.06 | 27.03 | 7.31 | 6.88 | 6.02 | 1.64 | Upgrade
|
| Working Capital | 92.43 | 115.55 | 12.93 | 65.23 | 99.93 | -1.19 | Upgrade
|
| Book Value Per Share | 3.44 | 4.23 | 1.65 | 9.40 | 15.28 | -3.50 | Upgrade
|
| Tangible Book Value | 92.97 | 114.29 | 12.08 | 64.72 | 91.97 | -5.73 | Upgrade
|
| Tangible Book Value Per Share | 3.44 | 4.23 | 1.65 | 9.40 | 15.28 | -3.50 | Upgrade
|
| Machinery | - | 1.48 | 1.49 | 1.45 | 1.29 | 1.02 | Upgrade
|
| Leasehold Improvements | - | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.